Fiji HIV Crisis Looms as Injecting-Drug Use Surges, WHO Projects 25,000 by 2029

Fiji is facing a significant HIV crisis among individuals who inject drugs, with projections indicating that infections could soar to 25,000 by 2029 without immediate intervention, according to a newly released rapid assessment by the World Health Organization (WHO). The report outlines critical issues contributing to the epidemic, including high-risk injecting practices, a lack of access to sterile equipment, limited awareness of HIV and hepatitis, and the stigma surrounding drug use.

Notably, the increasing use of crystal methamphetamine has raised concerns, as many users are transitioning quickly from smoking to injecting the drug. This trend, combined with the high mobility among the Pacific island nations, raises alarms about the potential for similar outbreaks in neighboring countries if urgent measures are not undertaken.

The WHO assessment emphasizes the urgent need for a cohesive response from various stakeholders, including health workers, religious leaders, and the affected communities. There is a consensus that effective, evidence-based, and culturally suitable interventions are essential to combat this looming health crisis. WHO experts have highlighted the importance of expanding harm reduction programs, enhancing access to HIV testing, and improving treatment services to mitigate the epidemic’s impact.

A collaborative regional approach is deemed crucial for safeguarding not just Fiji but also other islands in the Pacific. As emphasized in the assessment, “no island nation is secure unless all islands proactively strengthen their HIV prevention, diagnosis, treatment, and surveillance systems.” A united strategy would enhance health security and build collective resilience against public health threats.

Moreover, the report reveals a significant level of support for implementing compassionate, evidence-based responses to this health crisis. Recommendations from the WHO focus on urgently providing low-threshold access to sterile needles and syringes through various channels, including pharmacies, community organizations, and peer networks.

As stakeholders rally for swift action, there remains hope that with comprehensive strategies and community engagement, Fiji can turn the tide against rising HIV infections and establish robust health measures that protect both its citizens and the broader Pacific region.